Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
Inhibiting tyrosine kinases: successes and limitations.
Carlos L. Arteaga
Simmons Comprehensive Cancer Center - Administration - Directors Office - Administration
Simmons Comprehensive Cancer Center
Research output
:
Contribution to journal
›
Review article
›
peer-review
24
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Inhibiting tyrosine kinases: successes and limitations.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Protein-Tyrosine Kinases
100%
Gastrointestinal Stromal Tumors
65%
Trastuzumab
65%
Imatinib Mesylate
62%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
57%
Natural History
55%
ErbB Receptors
52%
Neoplasms
35%
Breast Neoplasms
35%
Population
21%